Diane Mary Coe
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Diane Mary Coe.
Medicinal Research Reviews | 1999
David H. Drewry; Diane Mary Coe; Steve Poon
The current interest in solid‐phase organic synthesis has led to a renewed interest in a complementary technique in which solid supported reagents are used in solution phase chemistry. This technique obviates the need for attachment of the substrate to a solid‐support, and enables the chemist to monitor the reactions using familiar analytical techniques. The purpose of this review is to increase awareness of the wide range of useful transformations which can be accomplished using solid‐supported reagents.
Bioorganic & Medicinal Chemistry Letters | 2000
Robert John Stevenage Young; Richard M. Beams; Keith Carter; Helen Alice Rebecca Clark; Diane Mary Coe; C.Lynn Chambers; P.Ifeyinwa Davies; John Dawson; Martin J. Drysdale; Karl Witold Franzman; Colin French; Simon T Hodgson; Harold Francis Hodson; Savvas Stevenage Kleanthous; Peter Rider; Daniela Sanders; David Alan Sawyer; Keith J Scott; Barry G Shearer; Richard Stocker; Steven Smith; Miriam C Tackley; Richard Graham Knowles
The synthesis and in vitro evaluation of the acetamidine derivatives of hetero-substituted lysine and homolysine analogues have identified potent inhibitors of human nitric oxide synthase enzymes, including examples with marked selectivity for the inducible isoform.
Angewandte Chemie | 2012
Edward I. Balmond; Diane Mary Coe; M. Carmen Galan; Eoghan M. McGarrigle
Alpha rules: A thiourea acts as an efficient organocatalyst for the glycosylation of protected galactals to form oligosaccharides containing a 2-deoxymonosaccharide moiety. The reaction is highly stereoselective for α-linkages and proceeds by way of a syn-addition mechanism.
Journal of Medicinal Chemistry | 2010
Panayiotis A. Procopiou; Victoria J. Barrett; Nicola Bevan; Keith Biggadike; Philip Charles Box; Peter R. Butchers; Diane Mary Coe; Richard Conroy; Amanda Emmons; Alison J. Ford; Duncan S. Holmes; Helen Tracey Horsley; Fern Kerr; Anne-Marie Li-Kwai-Cheung; Brian Edgar Looker; Inderjit Singh Mann; Iain M. McLay; Valerie S. Morrison; Peter J. Mutch; Claire E. Smith; Paula Tomlin
A series of saligenin beta(2) adrenoceptor agonist antedrugs having high clearance were prepared by reacting a protected saligenin oxazolidinone with protected hydroxyethoxyalkoxyalkyl bromides, followed by removal of the hydroxy-protecting group, alkylation, and final deprotection. The compounds were screened for beta(2), beta(1), and beta(3) agonist activity in CHO cells. The onset and duration of action in vitro of selected compounds were assessed on isolated superfused guinea pig trachea. Compound 13f had high potency, selectivity, fast onset, and long duration of action in vitro and was found to have long duration in vivo, low oral bioavailability in the rat, and to be rapidly metabolized. Crystalline salts of 13f (vilanterol) were identified that had suitable properties for inhaled administration. A proposed binding mode for 13f to the beta(2)-receptor is presented.
Tetrahedron Letters | 1995
Scott E. Denmark; Beritte L. Christenson; Diane Mary Coe; Stephen P. O'Connor
Abstract The rate and selectivity of catalytic enantioselective cyclopropanation of cinnamyl alcohol utilizing bisiodomethyl zinc and 4a/4b is greatly dependent on the order of addition of the reagents. The independent preformation of the ethylzinc cinnamyloxide and bis(iodomethyl)zinc was found to be crucial. The reaction displayed autocatalytic behavior which was shown to be due to the generation of zinc iodide.
Angewandte Chemie | 2014
Edward I. Balmond; David Benito-Alifonso; Diane Mary Coe; Roger W. Alder; Eoghan M. McGarrigle; M. Carmen Galan
A practical approach has been developed to convert glucals and rhamnals into disaccharides or glycoconjugates with high α-selectivity and yields (77–97 %) using a trans-fused cyclic 3,4-O-disiloxane protecting group and TsOH⋅H2O (1 mol %) as a catalyst. Control of the anomeric selectivity arises from conformational locking of the intermediate oxacarbenium cation. Glucals outperform rhamnals because the C6 side-chain conformation augments the selectivity.
Tetrahedron Letters | 1997
Geert-Jan Boons; Simeon G. Bowers; Diane Mary Coe
Abstract We have developed a novel glycosylation strategy in which a tritylated thioglycoside can act as a glycosyl donor and acceptor. In combination with previously reported chemoselective glycosylations, this feature enables highly convergent assembly of oligosaccharides
Journal of Organic Chemistry | 1993
Scott E. Denmark; Brian D. Griedel; Diane Mary Coe
O-(Silacyclobutyl) ketene acetals derived from esters, thiol esters, and amides reacted with a variety of aldehydes at room temperature without the need for catalysts. The O,O-ketene acetal of E-configuration reacted rapidly to afford the syn aldol products with high diastereoselectivity (93/7-99/1)
Tetrahedron Letters | 2001
J. P. S. Badyal; Audrey Cameron; Neil R. Cameron; Diane Mary Coe; Richard Cox; Benjamin G. Davis; Leslie J. Oates; Gisle Øye; Patrick G. Steel
Abstract Non-aqueous solutions of Ellmans reagent [5,5′-dithio(2-nitrobenzoic acid), DTNB] can be used to quantify thiols supported on macroporous polystyrene and TentaGel resins. Organic solutions of Ellmans reagent may also be used as a qualitative tests for thiols on a wider range of solid supports.
Journal of Medicinal Chemistry | 2009
Panayiotis A. Procopiou; Victoria J. Barrett; Nicola Bevan; Keith Biggadike; Peter R. Butchers; Diane Mary Coe; Richard Conroy; Dean David Edney; Rita Field; Alison J. Ford; Stephen Barry Guntrip; Brian Edgar Looker; Iain M. McLay; Michael John Monteith; Valerie S. Morrison; Peter J. Mutch; Stephen A. Richards; Rosemary Sasse; Claire E. Smith
A series of saligenin alkoxyalkylphenylsulfonamide beta(2) adrenoceptor agonists were prepared by reacting a protected saligenin oxazolidinone with alkynyloxyalkyl bromides, followed by Sonogashira reaction, hydrogenation, and deprotection. The meta-substituted primary sulfonamide was more potent than the para- and the ortho-analogues. Primary sulfonamides were more potent than the secondary and tertiary analogues. The onset and duration of action in vitro of selected compounds was assessed on isolated superfused guinea pig trachea. Sulfonamide 29b had the best profile of potency, selectivity, onset, and duration of action on both guinea pig trachea and human bronchus. Furthermore, 29b was found to have low oral bioavailability in rat and dog and also to have long duration of action in an in vivo model of bronchodilation. Crystalline salts of 29b were identified that had suitable properties for inhaled administration. A proposed binding mode for 29b to the beta(2)-receptor is presented.